compounded tirzepatide shortage FDA Allows During Review sustainable wellness goals. A Major GLP-1 Drug Shortage

PMID: 2 Abu-NejimH.BeckerR

Individuals with severe gastrointestinal problems such as gastroparesis (delayed stomach emptying) or a history of severe pancreatitis (inflammation of the pancreas) should not use tirzepatide, as it can aggravate these conditions

People struggling with gastroparesis have uncomfortable symptoms during digestion, and they can also experience longer-lasting side effects

For some people, medications like tirzepatide and phentermine might offer the extra help they need to reach their weight loss goals, but it is essential to use them carefully and under a doctors supervision

More recent studies temper the alarm, suggesting the apparent loss comes largely from liver and other tissue rather than skeletal muscle, and that strength is mostly preserved